1 x 106 cells/ml T4-positive PBL from a patient with S~zary syndrome or normal donors obtained by methods described in detail previously (13) were incubated in the presence of TPA (10 ng/ml), PHA (0.5 p.g/ml), or both for 24 h at 37°C. The surface profile of the cells before culture was determined by indirect immunofluorescence. * Incorporation of [aH]thymidine by 2.5 × 10 a 11-2-dependent Tn cells after 48 h of culture in the presence of 25% (vol/ vol) culture supernatants obtained from activated normal or Sfizary T cells (cpm --. SD from six replicates).
depletion and subsequent complement-dependent negative selection procedures, as described in detail previously (12) . Cells were cultured in a water-saturated atmosphere at 37°C, 5% CO2.
Surface Marker Analysis. Cell surface markers were determined using monoclonal mouse anti- Results and Discussion Table I shows that TPA causes the secretion of 11-2 by human leukemic T cells from a patient with S~zary syndrome, expressing the T4 +, T8-, T11 + cell surface phenotype. This surface phenotype has been shown to be characteristic for human T helper cells (1), including the II-2 producer cells (12) . In contrast, in peripheral T4 +, T8-, T11 + lymphocytes from normal donors, TPA itself causes no significant II-2 production, but acts synergistically in the PHA-mediated activation of I1-2 producer cells, possibly by substituting for the macrophage product 11-1 (13) . If the cell surface phenotype of such cells is analyzed after 18 h of culture, TPA causes both normal and malignant (S~zary) T lymphocytes to convert from T4-positivite to T4-negative cells (Table II) . The expression of the T cell antigens T3, T6, T8, T11, the Ia-antigen, and surface Ig-bearing B cells is not affected. The data in Fig. 1 (left panel) demonstrate that the abrogation of the expression of the T4 marker occurs at a TPA concentration as low as 0.6 ng/ml and is complete at 2.5 ng/ml. Furthermore, Fig. 1 (right panel) shows that this process requires time, as 50% of the initially T4-positive cells are T4 negative after ~4.5 h incubation time at 37°C and are completely negative after 8 h. Moreover, the T4 marker disappearance occurs only at 37°C but not at 4°C (Fig. 1) . The data in Table III show that the T4 0.5 X l0 s cells/ml normal or Sgzary-PBL were pulsed for 18 h with 5 ng/ml TPA. Cells were then washed three times and kept in culture medium (5% fetal calf serum), which was replaced by fresh medium after repeated washings and readjustment of the cell concentration to 0.5 X 10 n cells/ml after 42 and 66 h. At the time points indicated, percentage of T4-and Tl 1-positive cells was determined. * Denotes percent of positive cells in immunofluorescence.
The cells did not express the T4 antigen 138 h after onset of the culture when they were reexposed to TPA (5 ng/ml) after the washing procedures at 18, 42, and 66 h, respectively. § Cells not pulsed with TPA did not change antigen profile during culture. disappearance is reversible. Thus, when PBL were pulsed for 18 h with TPA, then washed repeatedly every 24 h, the T4 marker expectedly disappeared initially. However, between 66 and 138 h after onset of the cultures, a complete T4 reexpression was observed. The nature of the T4-positive target cells seems to be irrelevant, as not only cells from normal or leukemic donors, but also the leukemic T cell lines MOLT4 and JURKAT respond similarly under the influence of TPA (data not given). This finding is in good agreement with Delia et al. (9), who described similar observations using T-ALL cell lines.
TABLE IV

Effect of Phorbol andDifferent Esters on Cells Surface Markers
In a number of systems, a rigid relationship between the chemical structure of phorbol and its esters and a variety of biological effects has been described (2). We, therefore, investigated the effect of TPA, 4fl-PDD, 4a-PDD, and phorbol itself on the expression of the T4 antigen. Table IV shows that only the tumor-promoting agents (i.e., TPA and 4fl-PDD) cause abrogation of the T4-antigen expression, while 4a-PDD and phorbol fail to do so.
One interpretation of our results would be that TPA and 4fl-PDD modulate the cellular binding site recognized by the anti-T4-antibody, thus decreasing the net binding affinity. This type of mechanism has been reported for the TPA-mediated decrease in binding of epidermal growth factor (14) . Alternatively, tumor-promoting phorbol esters may decrease the number of anti-T4 antibody-binding sites by shedding mechanisms or internalization and subsequent degradation of the relevant binding components. Removal of TPA from the system would lead to synthesis of new T4 molecules. This argument is favored by the finding that 48 120 h were required for the T4 marker to reappear after an 18-h TPA pulse, despite repeated and vigorous washings of the cells. However, it has to be taken into consideration that, because of the highly lipophilic nature of TPA, it might be difficult to remove TPA completely.
Only tumor-promoting phorbol esters, but not inactive compounds, seIectiveIy affect the expression of the T4 antigen on T lymphocytes (Table I, ref. 2). This finding suggests that selective, yet unknown TPA-mediated modulations in anti-T4 antibody interaction with its binding site may be related to the mechanisms by which tumor promoters affect the growth pattern of normal or malignant cells. It can now be studied, inasmuch as the T4 antigen on T lymphocytes is required for the cells to exert immune functions. For example, T4-positive T cells produce a variety of lymphokines (I, 21), including I1-2 (12) . Under the conditions used in the experiments in Table I , TPA-induced II-2 production in Sfizary T cells reaches its maximum after 24 h. However, the II-2 producer cells are already T4 negative after 8 h in culture (Fig. 1) . Thus, it appears that there exists no stringent correlation between the expression of the T4 antigen and the ability to function as an II-2-producing T helper cell. Summary 12-O-tetradecanoylphorbol-13-acetate (TPA) selectively abrogates, in nanomolar concentrations, the expression of the T4 differentiation antigen, as defined by the monoclonal anti-T4 antibody (1) on I1-2-producing T helper lymphocytes from normal donors and on T helper lymphocytes from a patient with malignant T cell lymphoma (S~zary's syndrome); this compound does not affect the expression of cell surface antigens as defined by the antibodies anti-OKT3, -T6, -TS, -T11, Ia, or antisurface immunoglobulin. Abrogation of the T4 antigen expression is concentration dependent, completed within 8 h of incubation at 37°C, does not occur at 4°C, and is reversible. Only those phorbol-esters known to have tumor-promoting activity in vivo (2) affect the T4 antigen, whereas nonpromoting compounds are ineffective.
